Annals of Surgical Oncology

, Volume 19, Supplement 3, pp 528–538 | Cite as

Association of FANCC and PTCH1 with the Development of Early Dysplastic Lesions of the Head and Neck

  • Amlan Ghosh
  • Susmita Ghosh
  • Guru Prasad Maiti
  • Sudeshna Mukherjee
  • Nupur Mukherjee
  • Jayanta Chakraborty
  • Anup Roy
  • Susanta Roychoudhury
  • C. K. Panda
Translational Research and Biomarkers



Alteration of chromosome 9q22.3 region is an early and frequent event in head and neck squamous cell carcinoma (HNSCC). The aim of this study was to understand the association of candidate tumor suppressor genes PHF2, FANCC, PTCH1, and XPA located in this region in the development of HNSCC.


The alterations (deletion, promoter methylation, mutation, expression) of these genes were analyzed in 65 dysplastic head and neck lesions and 84 primary HNSCC samples. Clinicopathologic correlations were made with alterations of the genes.


Overall alterations (deletion, promoter methylation) of FANCC and PTCH1 were high in mild dysplasia and comparable in subsequent stages of tumor progression. However, PHF2 alteration was low in mild dysplasia, but increased in moderate and severe dysplasias. Alterations (deletion, promoter methylation) of FANCC and PTCH1 showed association with each other. Two novel mutations in GLI binding sites of PTCH1 promoter and a novel microsatellite marker hmPTCH1 with four alleles at immediate upstream of the gene were identified. In a case-control study, the (CGG)7 allele of hmPTCH1 was found to be susceptible for HNSCC development. Concordance was seen in the expression (RNA, protein) of these genes with their molecular alterations.


Alterations of FANCC and PTCH1 could be used as molecular marker for early diagnosis and prognosis of HNSCC.


Basal Cell Carcinoma Fanconi Anemia Dysplastic Lesion Mild Dysplasia Neck Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank the director of Chittaranjan National Cancer Institute, Kolkata, India. Financial support for this work was provided by grants from DST (SR/SO/BB-22/2003 dt. 02.11.04) and DBT (BT/PR/5524/Med/14/649/2004 of dt. 29.11.2005), Government of India, to C.K.P. and S.R.; CSIR-JRF/NET fellowship grant (2-56/2002(I) EU.II) to A.G.; and UGC-NET fellowship grant (F.2-3/2000 (SA-I)) to S.G.

Conflicts of interest

The authors declare that they have no conflict of interests.

Supplementary material

10434_2011_1991_MOESM1_ESM.doc (83 kb)
Supplementary material 1 (DOC 83 kb)
10434_2011_1991_MOESM2_ESM.doc (76 kb)
Supplementary material 2 (DOC 76 kb)
10434_2011_1991_MOESM3_ESM.doc (41 kb)
Supplementary material 3 (DOC 41 kb)
10434_2011_1991_MOESM4_ESM.doc (34 kb)
Supplementary material 4 (DOC 34 kb)
10434_2011_1991_MOESM5_ESM.jpg (785 kb)
Supplementary material 5 (JPEG 786 kb)
10434_2011_1991_MOESM6_ESM.jpg (503 kb)
Supplementary material 6 (JPEG 503 kb)
10434_2011_1991_MOESM7_ESM.jpg (1.4 mb)
Supplementary material 7 (JPEG 1401 kb)


  1. 1.
    Tripathi A, Dasgupta S, Roy A, et al. Sequential deletions in both arms of chromosome 9 are associated with the development of head and neck squamous cell carcinoma in Indian patients. J Exp Clin Cancer Res. 2003;322:289–97.Google Scholar
  2. 2.
    Ordonez BP, Beauchemin M, Jordan RCK. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol. 2006;59:445–53.CrossRefGoogle Scholar
  3. 3.
    Kim MM, Califano JA. Molecular pathology of head and neck cancer. Int J Cancer. 2004;112:545–53.PubMedCrossRefGoogle Scholar
  4. 4.
    Shao JY, Zeng WF, Zeng YX. Molecular genetic progression on nasopharyngeal carcinoma. Ai Zheng. 2002;21:1–10.PubMedGoogle Scholar
  5. 5.
    Sinha S, Singh R, Alam N, et al. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma. Mol Cancer. 2008;7:84.PubMedCrossRefGoogle Scholar
  6. 6.
    Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003;129:106–12.PubMedCrossRefGoogle Scholar
  7. 7.
    Freie BW, Ciccone SLM, Li X, et al. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint. J Biol Chem. 2004;279:50986–93.PubMedCrossRefGoogle Scholar
  8. 8.
    Wreesmann VB, Estilo C, Eisele DW, et al. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2007;69:218–25.PubMedCrossRefGoogle Scholar
  9. 9.
    Sidransky D. Is human patched the gatekeeper of common skin cancers. Nat Genet. 1996;14:7–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Kogerman P, Krause D, Rahnama F, et al. Alternative first exon of PTCH1 are differentially regulated in vivo and may confer different functions to PTCH1 protein. Oncogene. 2002;21:6007–601.PubMedCrossRefGoogle Scholar
  11. 11.
    Danaee H, Karagas MR, Kelsey KT, et al. Allelic loss at Drosophila patched gene is highly prevalent in basal and squamous cell carcinomas of the skin. J Invest Dermatol. 2006;126:1152–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Ishiyama A, Hibi K, Koike M, et al. PTCH gene expression as a potential marker for esophageal squamous cell carcinoma. Anticancer Res. 2006;26(1A):195–8.PubMedGoogle Scholar
  13. 13.
    Wang Y, Spitz MR, Lee JJ, et al. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007;13:3753–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Bose S, Morgan LJ, Booth DR, et al. The elusive multiple self-healing squamous epithelioma (MSSE) gene: further mapping, analysis of candidates, and loss of heterozygosity. Oncogene. 2006;25:806–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Dasgupta S, Mukherjee N, Roy S, et al. Mapping of candidate tumor suppressor genes’ loci on human chromosome 3 in head and neck squamous cell carcinoma of Indian patient population. Oral Oncol. 2002;38:6–15.PubMedCrossRefGoogle Scholar
  16. 16.
    Ichimura K, Bolin MB, Goike HM, et al. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res. 2000;60:417–24.PubMedGoogle Scholar
  17. 17.
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C (T)) method. Methods. 2001;25:402–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Perrone F, Suardi S, Pastore E, et al. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2006;12:6643–51.PubMedCrossRefGoogle Scholar
  19. 19.
    Singh RK, Dasgupta S, Bhattacharya N, et al. Deletion in chromosome 11 and Bcl-1/cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma. J Cancer Res Clin Oncol. 2005;131:395–406.PubMedCrossRefGoogle Scholar
  20. 20.
    D’Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003;3:23–34.PubMedCrossRefGoogle Scholar
  21. 21.
    Wolf I, Bose S, Desmond JC, et al. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treat. 2007;105:139–55.PubMedCrossRefGoogle Scholar
  22. 22.
    Daya-Grosjean L, Couve-Privat S. Sonic hedgehog signaling in basal cell carcinoma. Cancer Lett. 2005;225:181–92.PubMedCrossRefGoogle Scholar
  23. 23.
    Goldschneider D, Mehlen P. Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene. 2010;29:1865–82.PubMedCrossRefGoogle Scholar
  24. 24.
    Adolphe C, Hetherington R, Ellis T, et al. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res. 2006;66:2081–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Hasenpusch-Theil K, Chadwick BP, Theil T, et al. PHF2, a novel PHD finger gene located on human chromosome 9q22. Mamm Genome. 1999;10:294–8.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  • Amlan Ghosh
    • 1
  • Susmita Ghosh
    • 1
  • Guru Prasad Maiti
    • 1
  • Sudeshna Mukherjee
    • 1
  • Nupur Mukherjee
    • 1
  • Jayanta Chakraborty
    • 2
  • Anup Roy
    • 3
  • Susanta Roychoudhury
    • 4
  • C. K. Panda
    • 1
  1. 1.Department of Oncogene RegulationChittaranjan National Cancer InstituteKolkataIndia
  2. 2.Cancer Center and Welfare HomeKolkataIndia
  3. 3.Department of PathologyMedical College and HospitalKolkataIndia
  4. 4.Human Genetics and Genomic DivisionIndian Institute of Chemical BiologyKolkataIndia

Personalised recommendations